Thomas, McNerney & Partners logo

Thomas, McNerney & Partners

North America, Connecticut, United States, Stamford

Description

Thomas, McNerney & Partners is a health care venture capital firm with approximately $600 million under management focused on investing in

Investor Profile

Thomas, McNerney & Partners has made 48 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series B (25%)
  • Series Unknown (19%)
  • Series A (15%)
  • Series C (15%)
  • Series D (13%)
  • Series F (4%)
  • Series E (4%)
  • Post Ipo Equity (4%)
  • Series G (2%)

Country Focus

  • United States (98%)
  • Israel (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Biopharma
  • Manufacturing
  • Genetics
  • Diabetes
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Thomas, McNerney & Partners frequently co-invest with?

H.I.G. Capital
North America, Florida, United States, Miami
Co-Investments: 5
Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 4
Accuitive Medical Ventures
North America, Georgia, United States, Duluth
Co-Investments: 4
Domain Associates
North America, California, United States, San Diego
Co-Investments: 6
Sanderling Ventures
North America, California, United States, San Mateo
Co-Investments: 4
Investor Growth Capital Limited
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 8
BDC Venture Capital
North America, Alberta, Canada, Calgary
Co-Investments: 3
Quaker BioVentures
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 3
Mayo Clinic Ventures
North America, Minnesota, United States, Rochester
Co-Investments: 4
Clarus Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 3

What are some of recent deals done by Thomas, McNerney & Partners?

VertiFlex

Carlsbad, California, United States

VertiFlex provides minimally invasive and motion preserving spinal surgery technologies to the international healthcare market.

Health CareHospitalMedical Device
Series UnknownMar 27, 2017
Amount Raised: $45,326,781
Torax Medical

Saint Paul, Minnesota, United States

Torax Medical develops an implantable device for the treatment of gastroesophageal reflux disease.

BiotechnologyHealth CareMedical Device
Series EJul 26, 2016
Amount Raised: $25,001,500
Invitae

San Francisco, California, United States

Invitae is a medical genetics company that bring comprehensive genetic information into mainstream medicine to improve healthcare.

BiotechnologyGeneticsHealth Care
Series FOct 13, 2014
Amount Raised: $120,000,000
SG Biofuels

Encinitas, California, United States

SGB is a bioenergy crop company using molecular breeding and biotechnology to develop elite hybrid seeds of Jatropha genetic material.

AgricultureBiotechnologyGeneticsRenewable Energy
Series CSep 9, 2014
Amount Raised: $11,000,000
Auspex Pharmaceuticals

La Jolla, California, United States

Auspex Pharmaceuticals is a deuteration company developing therapeutics for depressive disorders.

BiotechnologyHealth CarePharmaceutical
Series EJan 8, 2014
Amount Raised: $20,000,000
AxioMed Spine

Malden, Massachusetts, United States

AxioMed Spine develops products that restore the spinal function of patients with degenerative spine diseases.

Health CareMedicalMedical Device
Series DJan 10, 2013
Amount Raised: $3,600,000
Auspex Pharmaceuticals

La Jolla, California, United States

Auspex Pharmaceuticals is a deuteration company developing therapeutics for depressive disorders.

BiotechnologyHealth CarePharmaceutical
Series DNov 8, 2012
Amount Raised: $25,000,000
Cebix

La Jolla, California, United States

Cebix is a biopharmaceutical company developing treatments for diabetic complications that affect the function of nerves, kidneys and eyes.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series BOct 18, 2012
Amount Raised: $33,188,334
Torax Medical

Saint Paul, Minnesota, United States

Torax Medical develops an implantable device for the treatment of gastroesophageal reflux disease.

BiotechnologyHealth CareMedical Device
Series DSep 19, 2012
Amount Raised: $30,000,000
Tioga Pharmaceuticals

San Diego, California, United States

Tioga Pharmaceuticals develops therapies for the treatment of gastrointestinal diseases.

BiotechnologyPharmaceuticalTherapeutics
Series BApr 12, 2012
Amount Raised: $10,000,000